Cindy Vu-D'elia, DO
Family Medicine · Keller, TXNPI 1457842668
Payments from drug & device makers
Across 50 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$114
- GSK$80
- Idorsia Pharmaceuticals US Inc$80
- Abbott$71
- Lilly USA, LLC$62
- Boehringer Ingelheim$60
- plus $466 from 17 others
What the payments were for
- Food & beverage$932100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 7 | $114 |
| GSK | 4 | $80 |
| Idorsia Pharmaceuticals US Inc | 4 | $80 |
| Abbott | 4 | $71 |
| Lilly USA, LLC | 3 | $62 |
| Boehringer Ingelheim | 2 | $60 |
| Merck | 3 | $55 |
| Sanofi Pasteur Inc. | 2 | $51 |
| Novo Nordisk | 3 | $45 |
| Dynavax Technologies Corporation | 2 | $41 |
| AbbVie | 2 | $32 |
| Dexcom, Inc. | 2 | $30 |
| AstraZeneca | 2 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $17 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Seqirus USA Inc | 1 | $17 |
| Kaleo, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $13 |
How this compares
$932 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 20 | $28,789 |
| OzempicSemaglutide | 20 | $28,460 |
| EliquisApixaban | 17 | $20,276 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,214 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $3,896 |
| Levothyroxine Sodium | 124 | $2,488 |
| Bupropion XlBupropion Hcl | 36 | $1,215 |
| SynthroidLevothyroxine Sodium | 16 | $943 |
| Atorvastatin Calcium | 140 | $876 |
| Omeprazole | 71 | $773 |
| Losartan Potassium | 72 | $576 |
| Pregabalin | 27 | $566 |
| Amlodipine Besylate | 102 | $542 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $523 |
| Estradiol | 17 | $502 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $62 | $28,78920 claims |
| Novo NordiskOzempic | $45 | $28,46020 claims |
| PfizerEliquis | $114 | $20,27617 claims |
| GSKTrelegy Ellipta | $80 | $8,21413 claims |
| AstraZenecaSymbicort | $30 | $3,89618 claims |
| AbbVieSynthroid | $32 | $94316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Keller
- Gregory FullerKeller$11.6M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.